These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 23089276)

  • 1. The rheumatology of gout.
    Sundy JS
    Adv Chronic Kidney Dis; 2012 Nov; 19(6):404-12. PubMed ID: 23089276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on gout and hyperuricemia.
    Baker JF; Schumacher HR
    Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL;
    Postgrad Med; 2011 Nov; 123(6 Suppl 1):3-36. PubMed ID: 22156509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of urate-lowering therapies: managing the risks to gain the benefits.
    Keenan RT
    Rheum Dis Clin North Am; 2012 Nov; 38(4):663-80. PubMed ID: 23137576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
    Zychowicz ME; Pope RS; Graser E
    J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

  • 8. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
    N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout: a clinical syndrome illustrated and discussed.
    Bhansing KJ; van Bon L; Janssen M; Radstake TR
    Neth J Med; 2010 Sep; 68(9):352-9. PubMed ID: 20876915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic diseases: gout.
    Falasca GF
    Clin Dermatol; 2006; 24(6):498-508. PubMed ID: 17113968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febuxostat--treatment for hyperuricemia and gout?
    Moreland LW
    N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
    [No Abstract]   [Full Text] [Related]  

  • 13. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.
    Stevenson M; Pandor A
    Health Technol Assess; 2009 Oct; 13 Suppl 3():37-42. PubMed ID: 19846027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gout: what primary care physicians want to know.
    Dore RK
    J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S47-54. PubMed ID: 18830091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical inquiry. Are serum uric acid levels always elevated in acute gout?
    Leiszler M; Poddar S; Fletcher A
    J Fam Pract; 2011 Oct; 60(10):618-20. PubMed ID: 21977490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gout].
    Leclercq P; Malaise MG
    Rev Med Liege; 2004 May; 59(5):274-80. PubMed ID: 15264576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of hyperuricemia and gout].
    Pöllmann G; Kullich W; Klein G
    Wien Med Wochenschr; 1997; 147(16):382-7. PubMed ID: 9446417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F; Herrero-Beites AM
    Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of gout.
    Pittman JR; Bross MH
    Am Fam Physician; 1999 Apr; 59(7):1799-806, 1810. PubMed ID: 10208700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.